Publikationen, an denen er mitarbeitet José María Miró Meda (11)

2002

  1. Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine

    Antiviral Therapy, Vol. 7, Núm. 4, pp. 283-287

  2. Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors

    Journal of Acquired Immune Deficiency Syndromes, Vol. 29, Núm. 5, pp. 429-434

2001

  1. Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 560 × 106/1 [6]

    AIDS

  2. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

    AIDS, Vol. 15, Núm. 9

2000

  1. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection

    AIDS, Vol. 14, Núm. 13, pp. 1921-1933

  2. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus- infected patients receiving antiretroviral therapy

    Clinical Infectious Diseases, Vol. 30, Núm. 2, pp. 392-394

1999

  1. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

    AIDS, Vol. 13, Núm. 11

1998

  1. Changes in HIV-1 RNA viral load following tuberculin skin test [7]

    Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

  2. Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection

    AIDS, Vol. 12, Núm. 11, pp. 1285-1289

  3. Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients

    Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 19, Núm. 1, pp. 55-60

1997

  1. Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 106/l

    AIDS, Vol. 11, Núm. 1, pp. 53-57